Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model

Experimental Oncology

Volumn 30, Issue 1, 2008, Pages 60-64

  Zhao, T ^a   Xia, W H ^a   Zheng, M Q ^a   Lu, C Q ^b   Han, X ^a   Sun, Y J ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Changzhou First Hospital   (China)

Author keywords

Breast cancer; Matrix metalloproteinases 9; Metastasis; Surgical wound; Vascular endothelial growth factor

Indexed keywords

GELATINASE B; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CANCER CELL; CANCER GROWTH; CANCER MODEL; CANCER SURGERY; CELL INTERACTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST CELL; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; SURGICAL WOUND; TISSUE LEVEL; TUMOR PROMOTION; TUMOR XENOGRAFT; ZYMOGRAPHY;

ANIMALS; BREAST NEOPLASMS; CARCINOMA; CELL PROLIFERATION; FEMALE; HUMANS; LUNG NEOPLASMS; MASTECTOMY; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM, RESIDUAL; TUMOR BURDEN; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42049103665     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No5, Lyon: IARC Press, 2001.
2. th ed. Devita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia: JB Lippincott Co 1993; 134-49.
3. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
4. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1997; 79: 315-28.
5. Hofer SO, Shrayer D, Reichner JS, et al. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg 1998; 133: 383-9.
6. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-44.
7. Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007; 82: 1375-81.
8. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993; 67: 1126-31.
9. Rha SY, Kim JH, Roh JK, et al. Sequential production and activation of matrix-metalloproteinase-9 (mmp-9) with breast cancer progression. Breast Cancer Res Treat 1997; 43: 175-81.
10. Stetler-Stevenson WG, Liotta LA, Kleiner DE, Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. Faseb J 1993; 7: 1434-41.
11. Kim J, Yu W, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998; 94: 353-62.
12. Gorden DL, Fingleton B, Crawford HC, et al. Resident stromal cell-derived mmp-9 promotes the growth of colorectal metastases in the liver microenvironment. Int J Cancer 2007; 121: 495-500.
13. Nikkola J, Vihinen P, Vuoristo MS, et al. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 2005; 11: 5158-66.
14. Atlas E, Cardillo M, Mehmi I, et al. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo. Mol Cancer Res 2003; 1: 165-75.
15. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9-34.
16. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000; 5: 37-44.
17. Lee JC, Chow NH, Wang ST, Huang SM. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 2000; 36: 748-53.
18. Cascinu S, Staccioli MP, Gasparini G, et al. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 2000; 6: 2803-7.
19. Homsi J, Daud AI. Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors. Cancer Control 2007; 14: 285-94.
20. Mira E, Lacalle RA, Buesa JM, et al. Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP-9 bound to the tumor cell surface. J Cell Sci 2004; 117: 1847-57.
21. Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factorpromote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 2000; 60: 4932-8.
22. Roh JL, Sung MW, Park SW, et al. Celecoxib can prevent tumor growth and distant metastasis in postoperative setting. Cancer Res 2004; 64: 3230-5.
23. Stuelten CH, DaCosta Byfield S, Arany PR, et al. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J Cell Sci 2005; 118: 2143-53.
24. Tuxhorn JA, McAlhany SJ, Dang TD, et al. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 2002; 62: 3298-307.
25. Drife JO. Breast development in puberty. In Endocrinology of the Breast: Basic and Clinical Aspects. Ann New York Acad Sci. Angeli A, Bradlow HL, Dogliotti L. eds. New York: The New York Academy of Sciences 1986; 58-65.
26. Chiquet-Ehrissmann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47: 131-39.
27. Singer C, Rasmussen A, Smith HS, et al. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res 1995; 55: 2448-54.
28. Yee D, Rosen N, Favoni RE, Cullen KJ. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. Cancer Treat Res 1991; 53: 93-106.
29. McDaniel SM, Rumer KK, Biroc SL, et al. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol 2006; 168: 608-20.
30. Grey AM, Schor AM, Rushton G, et al. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA 1989; 86: 2438-42.
31. Camps JL, Chang SM, Hsu TC. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 1990; 87: 75-9.